- Filed
- May 1, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 29, 2025 | 20.49M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $69.92M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $68.32M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $2.5M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $2.5M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $14.71M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $14.29M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $253.92M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $250.97M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $111.76M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $114.1M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $229.64M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $233.29M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $296.91M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $289.02M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $670.64M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $671.34M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 19.62M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $936K |
| Capex | Q1 2025 · Mar 31, 2024 | $2.97M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $13.44M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.01 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.01 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $15.98M |
| Net Income | Q1 2025 · Mar 31, 2024 | $2.56M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $6.69M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $42.35M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $124.52M |
| Revenue | Q1 2025 · Mar 31, 2024 | $166.87M |